Research Antibodies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product Type (Primary Antibodies, Secondary Antibodies), By Type (Monoclonal Antibodies, Polyclonal Antibodies), By Technology (Immunohistochemistry, Immunofluorescence, Western Blotting, Flow Cytometry, Immunoprecipitation, ELISA, Others), By Source (Mouse, Rabbit, Goat, Others), By
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationResearch Antibodies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product Type (Primary Antibodies, Secondary Antibodies), By Type (Monoclonal Antibodies, Polyclonal Antibodies), By Technology (Immunohistochemistry, Immunofluorescence, Western Blotting, Flow Cytometry, Immunoprecipitation, ELISA, Others), By Source (Mouse, Rabbit, Goat, Others), By
| Forecast Period | 2024-2028 |
| Market Size (2023) | USD 1.89 billion |
| CAGR (2023-2028) | 6.89% |
| Fastest Growing Segment | Oncology |
| Largest Market | North America |
Market Overview
Key Market Drivers
Increasing Investment In R&D
Increase In Research Academies and Industry Collaborations
Growing Stem Cells and Neurobiology Research
Rise In Proteomics and Genomics Research
Key Market Challenges
Growing Demand for Personalized Medicine and Rising Focus on Biomarker Discovery
Increasing Opportunities In Various Emerging Markets
Key Market Trends
Rise of Monoclonal Antibodies
Single-Cell Analysis
Segmental Insights
Product Insights
Type Insights
Regional Insights
Recent Developments
- In July 2023, Bio-TechneCorporation announced the completion of acquisition of Lunaphore. The intent ofthis business decision was to augment the companies’ spatial biology leadershipin the fields of translational and clinical research.
- In June 2023, Cell SignalingTechnology (CST) announced its partnership with Lunaphore. This initiative wasaimed at enabling the deployment of CST antibodies on the COMET platform byLunaphore for strengthening fully-automated spatial biology.
- In April 2023, abcam teamed upwith Lunaphore to co-commercialize primary antibodies from abcam. Theseantibodies were precisely validated for use on the COMET platform by Lunaphore.
- In April 2023, Bio-Techne enteredinto a partnership with Lunaphore. The aim of this deal was to develop thefirst in the world fully automated spatial multi-omics workflow enablingsame-slide hyperplex detection of RNA biomarkers and protein.
Key Market Players
- Abcam Plc
- MerckKGaA
- CellSignaling Technology, Inc.
- PerkinElmer,Inc.
- Bio-TechneCorporation
- JacksonImmunoResearch Inc
- ProteintechGroup, Inc.
- Becton,Dickinson and Company
- SantaCruz Biotechnology Inc.
- ThermoFisher Scientific, Inc.
| By Product Type | By Type | By Technology | By Source | By Application | By End Use | By Region |
|
|
|
|
|
|
|
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy